Latest China Startup Funding Rounds
Startup funding in China: recent rounds, the companies behind them and their participating investors.
- Rounds
- 87 Jan 1 – Oct 24, 2026
- Disclosed funding
- $4.9B 29 disclosed amounts
- Median round
- $72.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| ET Excalipoint TherapeuticsCompany profile Develops next-generation T-cell engager therapies for cancer and autoimmune diseases Develops next-generation T-cell engager therapies for cancer and autoimmune diseases | $27.7M | Seed+Seed | Biotech | China | Investors | |
| TA Today AICompany profile Today AI develops a personal assistant that uses memory and context to help users organise information and complete tasks. Today AI develops a personal assistant that uses memory and context to help users organise information and complete tasks. | Undisclosed | AngelSeed | AI | China | Investors | |
| F FireplaceCompany profile Provides a professional trading terminal for prediction markets with unified aggregation real-time data and institutional execution for traders Provides a professional trading terminal for prediction markets with unified aggregation real-time data and institutional execution for traders | $1.5M | Pre-SeedPre-seed | Fintech | China | Investors | |
| iC iSpace ChinaCompany profile iSpace China develops commercial launch vehicles and propulsion systems for satellite and constellation customers. iSpace China develops commercial launch vehicles and propulsion systems for satellite and constellation customers. | CN¥5B | Series D++Series C+ | Space tech | China | Investors | |
| IR Inference ResearchCompany profile Builds AI-native quantitative trading franchise combining digital assets and traditional finance Builds AI-native quantitative trading franchise combining digital assets and traditional finance | $20M | Seed | Fintech | China | Investors | |
| VT Develops intelligent, logic-gated therapeutics for solid tumors | $61M | Series A | Biotech | China | Investors | |
| OT Oricell TherapeuticsCompany profile Develops next-generation cell therapies for oncology and immunology Develops next-generation cell therapies for oncology and immunology | $70M | Series C1Series C+ | Biotech | China | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1HSG
Anew Labs, Math Magic, Full-Life Technologies
7rounds1led - 2IDG Capital
Anew Labs, Apex Intelligence, InfiMaker
7rounds2led - 3Qiming Venture Partners
Vivacta Biotechnology, Pulnovo Medical, Vivatides Therapeutics
7rounds—led - 4HongShan
Wuyuan Technology, 子午线光年, MoSense
6rounds0led - 5GL Ventures
Anew Labs, 子午线光年, LatentVerse
6rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.